Measuring compliance of package inserts in the Emirate of Abu Dhabi—UAE
暂无分享,去创建一个
[1] Jon Duke,et al. Consistency in the safety labeling of bioequivalent medications , 2013, Pharmacoepidemiology and drug safety.
[2] S. Al-Aqeel. Evaluation of medication package inserts in Saudi Arabia , 2012, Drug, healthcare and patient safety.
[3] Hadaya Gharibyar,et al. Evaluation of pharmaceutical drug information brochures in the Emirate of Abu Dhabi (United Arab Emirates) , 2012 .
[4] Y. Shivkar. Clinical information in drug package inserts in India. , 2009, Journal of postgraduate medicine.
[5] B. Svarstad,et al. Consumer medication information in the United States, Europe, and Australia: a comparative evaluation. , 2007, Journal of the American Pharmacists Association : JAPhA.
[6] P. Knapp,et al. A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. , 2007, Health technology assessment.
[7] S. Bawazir,et al. Comparative Study of Saudi-Marketed Products and US Drug Labeling , 1991, DICP : the annals of pharmacotherapy.
[8] D. Skene,et al. Attitudes of private medical practitioners towards package inserts and other drug information sources. , 1984, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[9] S. Fahmy,et al. Physicians' Perception of Drug Information Resources in the Emirate of Abu Dhabi-UAE * , 2013 .
[10] Requirements on content and format of labeling for human prescription drug and biological products. Final rule. , 2006, Federal register.
[11] J. Fuchs. A survey of package inserts use by patients , 2005 .
[12] Shayne C. Gad,et al. Investigative New Drug Application , 2005 .